OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Venetoclax and Hypomethylating Agent Combination in Myeloid Malignancies: Mechanisms of Synergy and Challenges of Resistance
Rahul Mishra, Maedeh Zokaei Nikoo, Sindhusha Veeraballi, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 484-484
Open Access | Times Cited: 8
Rahul Mishra, Maedeh Zokaei Nikoo, Sindhusha Veeraballi, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 484-484
Open Access | Times Cited: 8
Showing 8 citing articles:
Molecular subtypes of neuroendocrine carcinomas: A cross-tissue classification framework based on five transcriptional regulators
Zhanyu Wang, Chengming Liu, Sufei Zheng, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 1106-1125.e8
Closed Access | Times Cited: 11
Zhanyu Wang, Chengming Liu, Sufei Zheng, et al.
Cancer Cell (2024) Vol. 42, Iss. 6, pp. 1106-1125.e8
Closed Access | Times Cited: 11
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
Meike Vogler, Yannick Braun, Victoria M. Smith, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Meike Vogler, Yannick Braun, Victoria M. Smith, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
A phase 2 study of chidamide in combination with CAG and venetoclax-azacitidine in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis
Jingjing Yang, Qingyang Liu, Xiawei Zhang, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114268-114268
Closed Access
Jingjing Yang, Qingyang Liu, Xiawei Zhang, et al.
International Immunopharmacology (2025) Vol. 151, pp. 114268-114268
Closed Access
Repositioning of FDA-approved anti-cancer drugs for fatal blast crisis CML by integrated high-throughput genomic and artificial intelligence-based drug discovery analyses of pan-leukemic genetic abnormalities: Implications in post-COVID-19 era
Zafar Iqbal, Nawaf Alanazi, Sarah AlMukhaylid, et al.
Research Square (Research Square) (2025)
Closed Access
Zafar Iqbal, Nawaf Alanazi, Sarah AlMukhaylid, et al.
Research Square (Research Square) (2025)
Closed Access
Targeting regulated cell death pathways in cancers for effective treatment: a comprehensive review
Ruchi Saxena, Catherine F. Welsh, YouâWen He
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Ruchi Saxena, Catherine F. Welsh, YouâWen He
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1
Exploring Mechanisms of Action in Combinatorial Therapy through Stability/Solubility Alterations: Advancing AML Treatment
Elham Gholizadeh, Ehsan Zangene, Uladzislau Vadadokhau, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Elham Gholizadeh, Ehsan Zangene, Uladzislau Vadadokhau, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Recent advances in the role of atypical cadherin FAT1 in tumorigenesis (Review)
Tao Wang, Junting Li, Jun Du, et al.
Oncology Letters (2024) Vol. 29, Iss. 3
Open Access
Tao Wang, Junting Li, Jun Du, et al.
Oncology Letters (2024) Vol. 29, Iss. 3
Open Access
The DHODH inhibitor teriflunomide impedes cell proliferation and enhances chemosensitivity to daunorubicin (DNR) in T-cell acute lymphoblastic leukemia
Yang Li, Deyu Ma, Shan Liu, et al.
Annals of Hematology (2024)
Closed Access
Yang Li, Deyu Ma, Shan Liu, et al.
Annals of Hematology (2024)
Closed Access
